Study Reveals Exciting Physician Growth in the Areas of Mobile, Social, and Online Access

Manhattan ResearchPhysicians show continued adoption of mobile and social media for professional purposes, as well as increasing dependency on digital resources at the point of care, according to pharmaceutical and healthcare market research company Manhattan Research's latest Taking the Pulse® study of over 2,000 U.S. physicians. The tenth version of this landmark research and strategic advisory service is focused on which technologies physicians have adopted, how they are currently using them, and how they plan to use them in the future. Taking the Pulse® v10.0 provides a rich data set with topical insights for pharma marketers, agencies, physician content and technology providers, and other parties interested in connecting with physicians.

"In 2010, the conversation has shifted away from whether physicians are online to understanding the degree to which digital content is changing the way physicians practice medicine," said Meredith Ressi, VP of research at Manhattan Research. "Professional use of smartphones and online user-generated content are no longer early adopter activities of a tech-savvy few – these types of activities are the norm for the majority of physicians today."

Key topics covered in the research include:

  • Online and Offline Professional Information Sources: Online and offline information sources used, including textbooks, journals, conferences, CME, reps, search engines, sites visited
  • Mobile Technology Adoption: Device adoption by platform (iPhone, BlackBerry, Palm, Android); professional activities conducted on the smartphone; top mobile apps and websites used
  • Online User-Generated Content: Use of physician-only communities, messageboards and blogs
  • General Access and Technology Profile: Practice technology profile; frequency of Internet use; frequency of professional activities online and offline
  • Patient Interaction and Education: Patients bringing information into office; sites recommended to patients; types of patient education sources of interest
  • Digital Health Infrastructure: Adoption of electronic medical records (EMR); electronic prescribing; impact of ARRA on decision to implement EMR system

Webinar April 29 - Register Today

Mrs. Ressi will host a complimentary webinar previewing the research topics covered in the Taking the Pulse® v10.0 study on Thursday, April 29 at 11am EST.

Register here: https://www2.gotomeeting.com/register/907415971

About Taking the Pulse®
Taking the Pulse® v10.0 is a market research and strategic advisory service focused on which technologies physicians have adopted, how they are currently using them, and how they plan to use them in the future. The study was conducted in Q1 2010 via online and offline survey methodology among a nationally representative sample of 2,033 U.S. practicing physicians. Broad physician market research can be segmented to provide insights for over twenty specialist groups. For additional product and subscription information, please visit http://www.manhattanresearch.com/ttp.

About Manhattan Research
Manhattan Research, a Decision Resources, Inc. company, is a global pharmaceutical and healthcare market research and strategic advisory firm and conducts annual research studies covering eHealth trends among physicians and consumers, including Taking the Pulse®, Taking the Pulse® Nurses, Taking the Pulse® Europe, Taking the Pulse® Asia, Cybercitizen Health®, Cybercitizen Health® Europe, ePharma Consumer®, and ePharma Physician®. Broad consumer and physician research is complemented by targeted analysis for over 100 consumer therapeutic segments and physician specialist segments. For more information, please visit http://www.manhattanresearch.com.

About Decision Resources, Inc.
Decision Resources, Inc. is a cohesive portfolio of companies that offers best-in-class, high-value information and insights on important sectors of the healthcare industry. Clients rely on this analysis and data to make informed decisions. Please visit Decision Resources, Inc. at http://www.decisionresourcesinc.com.

Most Popular Now

Aspirin green light for brain bleed stroke patient…

People who suffer a stroke caused by bleeding in the brain - known as brain haemorrhage - can take common medicines without raising their risk of another stroke, a major ...

Cancer cells are quick-change artists adapting to …

Until now, researchers have assumed that the growth of solid tumors originates from cancer stem cells characterized by specific surface markers, which develop in a fixed...

APRINOIA Therapeutics awarded grant from The Micha…

APRINOIA Therapeutics, a clinical-stage biotechnology company with a pipeline of therapeutics and imaging diagnostics for neurodegenerative diseases, announces today that...

Benralizumab not effective reducing exacerbations …

More than 15.3 million people in the U.S. suffer from chronic obstructive pulmonary disease (COPD), which is the third leading cause of death in this country, according t...

Pfizer announces top-line results from Phase 3 Tri…

Pfizer Inc. (NYSE: PFE) announced today that a Phase 3 study to assess the use of LYRICA® (pregabalin) as adjunctive therapy for epilepsy patients 5 to 65 years of age wi...

Novartis phase II data for new inhaled combination…

Novartis announced today that new phase II data for IND/GLY/MF (QVM149), an investigational, once-daily, fixed dose combination asthma treatment containing indacaterol ac...

New data show Symbicort reduces attacks in mild as…

New data from Novel START, an open-label trial designed to reflect real-world practice, has demonstrated the effectiveness of Symbicort Turbuhaler (budesonide/formoterol)...

Cannabis use among older adults rising rapidly

Cannabis use among older adults is growing faster than any other age group but many report barriers to getting medical marijuana, a lack of communication with their docto...

Merck pioneers new effort to see MS from the insid…

Merck, a leading science and technology company, joins the global multiple sclerosis (MS) community in recognition of World MS Day, an initiative created by the Multiple ...

Amgen joins with community oncology networks for n…

Amgen (NASDAQ: AMGN), along with leading community oncology networks, today announced the launch of Amgen Community Oncology Research Collaborators (ACORC), a new initiat...

Bayer receives U.S. FDA breakthrough therapy desig…

Bayer announced today that the U.S. Food and Drug Administration (FDA) granted Breakthrough Therapy Designation for copanlisib (Aliqopa™) for the treatment of adult patie...

Roche's personalised medicine entrectinib shrank t…

Roche (SIX: RO, ROG; OTCQX: RHHBY) announced positive data from the Phase I/II STARTRK-NG study, evaluating the investigational medicine entrectinib in children and adole...